Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.33 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | NAMPT | P43490 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10021727 | 0.85 | FAAH (0.50) | CNR2L3MBTL1TSHRMAPTRECQL | |
| SCHEMBL2548314 | 0.83 | CYP1A2 (0.47) | CNR2L3MBTL1LMNATSHRMAPT | |
| SCHEMBL12362917 | 0.81 | CNR2 (0.52) | CNR2L3MBTL1FAAHGAA | |
| SCHEMBL26616605 | 0.81 | CYP1A2 (0.49) | CNR2L3MBTL1TSHRMAPTRECQL | |
| SCHEMBL29959771 | 0.79 | CNR2 (0.51) | CNR2L3MBTL1FAAHGAA | |
| SCHEMBL1449527 | 0.79 | FAAH (0.61) | CNR2L3MBTL1FAAH | |
| SCHEMBL30777859 | 0.79 | CNR2 (0.51) | CNR2L3MBTL1FAAHGAA | |
| SCHEMBL5909180 | 0.79 | LMNA (0.57) | LMNATSHRMAPTRECQLFAAH | |
| SCHEMBL3084079 | 0.78 | — | — | |
| SCHEMBL10226131 | 0.78 | FAAH (0.64) | CNR2L3MBTL1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230150969-A1 | BIOCONJUGATES AND ANTIBODIES FOR IMMUNODETECTION ASSISTED BY DERIVATIZATION OF THE MYCOTOXIN PATULIN | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) | 2023-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150969-A1 | BIOCONJUGATES AND ANTIBODIES FOR IMMUNODETECTION ASSISTED BY DERIVATIZATION OF THE MYCOTOXIN PATULIN | TMT1A, TST, TXNDC5 | CNR2 3631/4885L3MBTL1 2826/4885LMNA 3718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.